By Elie Dolgin Drug companies in the EU are increasingly embracing nonanimal ways of test medicines.

By Elie Dolgin Drug companies in the EU are increasingly embracing nonanimal ways of test medicines, but the true quantity of animals used for preliminary research is increasing, september by the European Commission according to statistics published 30 affect urinary system . Although the full total number of animals used for scientific reasons in the EU’s 27 member claims has held steady at around 12 million each year, this overall body masks shifting tendencies in animal experimentation. The European Commission record, which records data submitted for 2008, shows that studies investigating basic biological principles used 4 approximately.

used orally

Animal model of HIV sexual transmission Infection by human being immunodeficiency virus causes acquired immunodeficiency syndrome , a debilitating disorder in which progressive weakening of the disease fighting capability makes individuals more susceptible to potentially life-threatening infections and chronic diseases. Despite advances in the administration and treatment of AIDS, there is no get rid of, and HIV infections remains a major global medical condition. According to the WHO, there have been around 34 million infected people in 2011. During the last three decades, a true number of animal versions have already been developed to study aspects of HIV infection, pathogenesis and control. However, the currently available models usually do not recapitulate the physiological environment of the very most common route of HIV transmission worldwide, vaginal intercourse.